Why Trust Recovery Guide Gabapentin is a prescription anticonvulsant medication primarily used to treat seizures, nerve pain, and restless leg syndrome, but increasingly prescribed off-label for a wide range of conditions including anxiety and alcohol withdrawal. While it has historically been considered low-risk for misuse, gabapentin is now recognized as a drug of concern, particularly among people with opioid use disorder, who may misuse it to enhance the effects of opioids or manage withdrawal symptoms. As a result, specialized testing for gabapentin is becoming more common in clinical and legal settings.
Unlike most commonly tested substances, gabapentin is not detected on standard urine drug screens, identifying it requires a specialized test that screens for the drug. On average, gabapentin can be detected in urine for two to three days after the last dose, though that window can extend in people with impaired kidney function, since the kidneys are responsible for metabolizing and eliminating gabapentin from the body.
Detecting Gabapentin In Urine
Because gabapentin is not included in standard immunoassay urine panels, a specific add-on test must be ordered to detect its presence. A person could test positive for no substances on a standard drug screen while still having significant amounts of gabapentin in their system. Healthcare providers, legal entities, and treatment programs that want to screen for gabapentin use need to request it explicitly.
When a specialized test is used, gabapentin can typically be detected in urine for two to three days after the last dose under normal circumstances. However, this window can be much longer for people with impaired kidney function, in some cases up to 30 days, since the kidneys are the primary pathway through which gabapentin is cleared from the body.
People with kidney disease or other conditions that affect renal function should inform their doctor before taking gabapentin, as dosing adjustments are often necessary and detection times will be different.
What Factors Can Affect How Long Gabapentin Stays In Urine?
The average estimate for how long gabapentin stays in urine is two to three days after a person’s last dose. This can vary, however, according to several personal and biological factors.
Kidney Function
People who have impaired renal (kidney) function will likely have traces of gabapentin remain in their system for longer. This is because gabapentin is metabolized by the kidneys. If you have impaired kidney function, gabapentin may be detectable in urine for up to 30 days after last use. Be sure to tell your doctor if you have kidney problems before taking gabapentin.
Dosage
Taking high doses of gabapentin may affect how long it stays in urine.
Route Of Administration
How a drug enters the body can affect how long it stays in the system, based on how quickly it reaches the bloodstream. Injecting or smoking drugs, for instance, can result in shorter detection windows compared to swallowing or snorting.
Use Of Multiple Drugs/Polysubstance Abuse
Gabapentin may stay in urine for a longer amount of time if it’s taken with other drugs, including other prescription drugs, illicit substances, and alcohol.
Metabolic Rate
The rate of a person’s metabolism can affect how long it takes to pass through a person’s system. Older age, poor health, and hypometabolic conditions may cause a longer detection time for gabapentin in urine.
Getting Gabapentin Out Of Your System
People who are physically dependent on gabapentin may have a difficult time stopping their gabapentin use on their own. If you’ve been taking gabapentin for more than a few weeks, talk to your doctor before trying to reduce your dose or stop taking gabapentin.
Stopping gabapentin all at once may trigger withdrawal symptoms, such as anxiety, pain, sweating, nausea, and difficulty sleeping.
Finding Treatment For Gabapentin Misuse
Browse our directory or reach out to the Substance Abuse and Mental Health Services Administration (SAMHSA) for more information about addiction recovery.
Addiction Resource aims to provide only the most current, accurate information in regards to addiction and addiction treatment, which means we only reference the most credible sources available.
These include peer-reviewed journals, government entities and academic institutions, and leaders in addiction healthcare and advocacy. Learn more about how we safeguard our content by viewing our editorial policy.
- JAMA Network—Gabapentinoid Use in the United States 2002 Through 2015
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2666788 - U.S. Food and Drug Administration (FDA)—Neurontin Label
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020235s043lbl.pdf - U.S. National Library of Medicine: Medline—Gabapentin
https://medlineplus.gov/druginfo/meds/a694007.html